Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Life (Basel, Switzerland)|January 21, 2022
Potential Use of CTCs as Biomarkers in Renal Cancer PatientsJoanna Bialek, Andreas Wencker, Felix Kawan, et al.
Plos One|August 2, 2016
The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept StudyGerit Theil, Kersten Fischer, Ekkehard Weber, et al.
World Journal of Urology|November 1, 2018
An overview of the ATOMS generations: port types, functionality and risk factorsSandra Mühlstädt, Alexander Friedl, Roman Zachoval, et al.
World Journal of Urology|July 3, 2013
Laparoscopic radical cystectomy with extracorporeal ileal neobladder for muscle-invasive urothelial carcinoma of the bladder: technique and short-term outcomesChristopher Springer, Nasreldin Mohammed, Stefano Alba, et al.
International Journal of Molecular Sciences|January 23, 2024
Photodynamic Therapy: Current Trends and Potential Future Role in the Treatment of Bladder CancerMaxim Kochergin, Omar Fahmy, Anastasios Asimakopoulos, et al.
World Journal of Urology|May 27, 2022
Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional studyGerit Theil, Michael Richter, Matthias Schulze, et al.
Oncology Letters|March 22, 2021
<i>In vivo</i> isolation of circulating tumor cells in patients with different stages of prostate cancerGerit Theil, Catrin Boehm, Kersten Fischer, et al.
World Journal of Urology|May 9, 2016
Five-year experience with the adjustable transobturator male system for the treatment of male stress urinary incontinence: a single-center evaluationSandra Mühlstädt, Alexander Friedl, Nasreldin Mohammed, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Cell-Free Methylated <i>PTGER4</i> and <i>SHOX2</i> Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC PatientsMichael Fleischhacker, Erkan Arslan, Dana Reinicke, et al.
European Journal of Human Genetics : EJHG|October 16, 2004
Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutationsKirsi Alakurtti, Ekkehard Weber, Riitta Rinne, et al.
Pageof 3